![Michael Albin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Albin
Directeur/Bestuurslid bij
Genturi, Inc.
Profiel
Michael Scott Albin is currently a Director at MOBILion Systems, Inc. and Genturi, Inc. He previously worked as a Non-Executive Director at Avacta Group Plc from 2014 to 2018.
He also held Director positions at Decipher Biosciences, Inc. and Aquyre Biosciences, Inc. Additionally, he was a Vice President at Applera Corp.
and Applied Biosystems, Inc. Dr. Albin holds a doctorate degree from The Pennsylvania State University and an undergraduate degree from New York University Tandon School of Engineering.
Actieve functies van Michael Albin
| Bedrijven | Functie | Begin |
|---|---|---|
Genturi, Inc.
 Genturi, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops nanofluidic device | Directeur/Bestuurslid | - |
MOBILion Systems, Inc.
 MOBILion Systems, Inc. Packaged SoftwareTechnology Services Develops spectrometry platform for conducting ion mobility separations with lossless ion transfer and manipulation | Directeur/Bestuurslid | - |
Eerdere bekende functies van Michael Albin
| Bedrijven | Functie | Einde |
|---|---|---|
| AVACTA GROUP PLC | Directeur/Bestuurslid | 30-03-2018 |
Aquyre Biosciences, Inc.
 Aquyre Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell-based therapies and regenerative medicine solutions | Directeur/Bestuurslid | - |
Applera Corp.
 Applera Corp. Medical SpecialtiesHealth Technology Manufactures medical instruments | Corporate Officer/Principal | - |
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Manufactures genomics and proteomics related research instruments | Hoofd Techniek/Wetenschap/O&O | - |
Veracyte SD, Inc.
 Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care | Directeur/Bestuurslid | - |
Opleiding van Michael Albin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
8
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Applera Corp.
Applera Corp. Medical SpecialtiesHealth Technology Manufactures medical instruments | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avacta Group Plc
 Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Manufactures genomics and proteomics related research instruments | Health Technology |
New York University Tandon School of Engineering
 New York University Tandon School of Engineering Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Veracyte SD, Inc.
Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care | Commercial Services |
MOBILion Systems, Inc.
MOBILion Systems, Inc. Packaged SoftwareTechnology Services Develops spectrometry platform for conducting ion mobility separations with lossless ion transfer and manipulation | Technology Services |
Genturi, Inc.
Genturi, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops nanofluidic device | Electronic Technology |
Aquyre Biosciences, Inc.
Aquyre Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell-based therapies and regenerative medicine solutions | Commercial Services |
